Morgan Stanley names SSAB a “top pick,” hikes target on U.S. plate strength

Morgan Stanley upgraded SSAB AB to overweight from equal-weight and raised its price target to SKr 94 from SKr 73, adding the stock to its Top Pick list. The broker cited improving earnings momentum, strength in the U.S. plate market, and lower energy-cost exposure, with EBITDA seen rising to SKr 14.01 billion in 2026 and SKr 15.92 billion in 2027. Shares closed at SKr 80.74, implying upside to the new target, though execution risks remain around the Oxelösund EAF project and the longer-term Luleå transformation.

Analysis

The key second-order effect is that this is less a simple cyclical steel upgrade than a re-rating of a cleaner, more levered earnings stream. If U.S. plate stays firm while input-cost exposure falls, margins can expand faster than headline volumes suggest, which matters because the market typically underwrites steel names on peak-to-trough earnings volatility rather than structural mix improvement. That makes SSAB more interesting versus integrated peers whose profits remain more hostage to energy and broader industrial demand swings.

The valuation setup is the real catalyst: the market is effectively discounting the next leg of EBITDA improvement as temporary even though the estimate path implies a multi-year earnings step-up. When a stock moves from a low-teens EBITDA multiple to a mid-single-digit multiple on rising earnings, the message is that investors are not paying for duration; if execution on the U.S. plate cycle and special steels persists for even 2-3 quarters, the multiple can compress less than modeled and drive outsized equity upside. The flip side is that this becomes vulnerable to any sign of plate normalization or a margin miss at the same time as capex ramps.

The contrarian risk is that the market may be overestimating how smoothly the transformation projects translate into cash flow. Industrial investors often underappreciate the lag between improved pricing and realized free cash flow when large asset conversions are underway; any slippage at Oxelösund could turn a quality re-rate into a capital-spend overhang. Near term, the stock can continue to grind higher on estimate revisions, but the real test is whether management can defend earnings while spending into 2027-2029, because that is where consensus usually gets too optimistic on steel transformations.

Key Decisions for Investors

• Long SSABa over the next 1-3 months on a momentum-plus-estimate-revision setup; risk/reward is attractive if U.S. plate pricing holds, with upside toward the revised target and downside limited unless margins roll over abruptly.
• Pair trade: long SSABa / short ArcelorMittal for a 3-6 month relative-value expression; SSAB should benefit more from lower energy exposure and cleaner earnings leverage, while the short leg carries more macro and input-cost beta.
• Use call spreads rather than outright equity for SSABa if liquidity is sufficient; a 6-12 month upside structure captures the re-rating while capping risk around project-execution headlines and cyclical steel volatility.
• Watch for any 1-2 quarter pause in U.S. plate momentum; if pricing weakens, reduce exposure quickly because the multiple assumption is doing a lot of work here and can compress faster than EBITDA rolls over.